A combination of soy isoflavones and cello-oligosaccharides changes equol/O-desmethylangolensin production ratio and attenuates bone fragility in ovariectomized mice

Biosci Biotechnol Biochem. 2016 Aug;80(8):1632-5. doi: 10.1080/09168451.2016.1184559. Epub 2016 May 18.

Abstract

We examined the cooperative effects of isoflavones and cello-oligosaccharides on daidzein metabolism and bone fragility in ovariectomized mice. Cello-oligosaccharides increased urinary equol and decreased O-desmethylangolensin. A combination of isoflavones and cello-oligosaccharides attenuated decreases in bone breaking force and stiffness caused by ovariectomy. Combination treatment with isofalvones and cello-oligosaccharides increases urinary equol/O-desmethylangolensin production ratio and prevents ovariectomy-induced abnormalities in bone strength.

Keywords: O-desmethylangolensin; cello-oligosaccharides; equol; isoflavones; osteoporosis.

MeSH terms

  • Absorptiometry, Photon
  • Animals
  • Bone Density / drug effects
  • Cellobiose / administration & dosage*
  • Equol / urine*
  • Female
  • Femur / drug effects
  • Femur / metabolism
  • Femur / pathology
  • Food, Formulated
  • Fractures, Bone / metabolism
  • Fractures, Bone / pathology
  • Fractures, Bone / prevention & control*
  • Genistein / urine
  • Glycine max / chemistry
  • Isoflavones / administration & dosage*
  • Isoflavones / urine
  • Mice
  • Ovariectomy*

Substances

  • Isoflavones
  • Cellobiose
  • Equol
  • daidzein
  • Genistein
  • O-desmethylangolensin